| 영문 | Dilatation and Curettage(D & C) | 한글 | 자궁긁어냄술, 자궁목확장 |
|---|---|---|---|
| 설명 | 자궁이란 태아가 수태되어서 분만전까지 발육하고 성장하는 공간이다. 자궁속에 병변이 있어 임신이 계속될 수 없거나 아니면 다른 이유로 임신되어 있는 태아를 제거하고자 할 경우에 사용되는 방법이다. 여기서 긁어내기 위하여는 우선 자궁의 입구에 해당하는 자궁목을 확장시켜야 한다. 여기에는 급속히 확장을 시도하는 법과 서서히 확장을 시도하는 2가지 방법이 있다. 자궁목을 급속히 확장할 때는 헤가르 목관확장기(Hegar's dilatator)를 사용한다. 이것은 작은 금속막대로 작은 크기부터 큰 크기까지 다양한 크기가 있어서 우선 작은 막대로 시작하여 점점 큰 크기의 막대를 자궁목에 넣어서 자궁목을 확장시킨다. 서서히 확장시킬 때는 Laminaria tent를 목관에 삽입하는 방법을 사용한다. Laminaria tent란 해초로 만든 작은 막대로 수분을 흡수하면 점점 늘어나는 성질이 있다. 이것을 자궁의 목에 넣으면 이것이 수분을 흡수하여 늘어나므로 천천히 자궁의 목이 늘어난다. 자궁목이 충분히 늘어나면 그 속으로 끝이 숟가락처럼 생긴 기구를 넣어서 자궁속의 병변이나 임신된 태아를 긁어내는데 여기에 사용되는 숟가락처럼 생긴 기구를 큐렛이라고 한다. 초기 임신중절 즉 유산과 같은 임신과 관련된 경우뿐만 아니라, 비임신 자궁의 자궁내막조직의 채취 및 제거를 위해서도 행해지는 수기이다. 이는 원칙적으로 마취하에 실시되는 것으로 자궁목관을 확장하고 기구로 자궁 내용물을 제거하고 큐렛으로 자궁내벽을 깨끗이 한다. 자궁천공이나 자궁목의 파열 등의 위험이 따르며, 수술후 감염 또는 출혈 등에 대한 주의가 필요하다. |
||
| TMP-SMX | trimethoprim-sulfamethaxole; trimethoprim-sulfamethoxazole |
|---|---|
| PBN | paralytic brachial neuritis; peripheral benign neoplasm; polymyxin B sulfate, bacitracin, and neomyc... |
| PLET | polymyxin, lysozyme, EDTA, and thallous acetate [in heart infusion agar] |
| SULF-PRIM | sulfamethoxazole and trimethoprim |
| BPN | bacitracin, polymyxin B, neomycin sulfate; brachial plexus neuropathy |
| OA | Ophthalmic Artery |
|---|---|
| SOV | superior ophthalmic vein |
| PB | Polymyxin B |
| PMX-B | Polymyxin B |
| PXB | Polymyxin B |
acute angle
| polymyxin | <chemical> Basic polypeptide antibiotic group obtained from bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. at least eleven different members of the polymyxin group have been identified, each designated by a letter. Pharmacological action: antibiotics, peptide. (12 Dec 1998) |
|---|---|
| polymyxin acylase | <enzyme> Deacylates polymyxin, colistin and octapeptin antibiotic Registry number: EC 3.5.1.- (26 Jun 1999) |
| polymyxin b | <chemical> A mixture of polymyxins b1 and b2, obtained from bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin b is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic. Pharmacological action: antibiotics, peptide. Chemical name: Polymyxin B (12 Dec 1998) |
| polymyxin B sulfate | An antibacterial effective in tularaemia, brucellosis, Pseudomonas infections, and urinary tract infections, but used systemically only for severe infections not responsive to less toxic agents; it is also used locally. Polymyxin B is a mixture of polymyxin B1 and polymyxin B2. (05 Mar 2000) |
| trimethoprim | <drug> A drug that inhibits the reduction of dihydrofolate to tetrahydrofolate (a later step than that inhibited by sulphonamides). Selective for some bacterial dihydrofolate reductases and often used in conjunction with sulphonamides. (19 Jan 1998) |
| trimethoprim resistance | Nonsusceptibility of a bacterium to the action of trimethoprim. (12 Dec 1998) |
| trimethoprim-sulfamethoxazole | A drug combination consisting of a dihydrofolate reductase inhibitor (trimethoprim) and a sulfonamide antibacterial drug (sulfamethoxazole). The drug combination is synergistic as the drugs interfere with two successive steps in the formation/utilization of folic acid by microorganisms. Used to treat many infectious diseases. (05 Mar 2000) |
| trimethoprim-sulfamethoxazole combination | <chemical> 4-amino-n-(5-methyl-3-isoxazolyl)benzenesulfonamide mixture with 5-((3,4,5-trimethoxyphenyl)methyl)- 2,4-pyrimidinediamine. This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including pneumocystis carinii pneumonia in aids, but is the drug of choice for urinary infection. Pharmacological action: anti-infective agents, anti-infective agents, urinary, antimalarials. Chemical name: Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, mixt. With 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine (12 Dec 1998) |
| meningeal branch of ophthalmic nerve | <anatomy, nerve> See: tentorial nerve. (05 Mar 2000) |
| superior ophthalmic vein | <anatomy, vein> Begins anteriorly from the nasofrontal vein, passes along the upper part of the medial wall of the orbit, passes through the superior orbital fissure, to empty into the cavernous sinus. Synonym: vena ophthalmica superior. (05 Mar 2000) |
| inferior ophthalmic vein | <anatomy, vein> Arises from the inferior palpebral and lacrimal veins and divides into two terminal branches, one of which runs to the pterygoid plexus while the other joins the superior ophthalmic vein or empties into the cavernous sinus. Synonym: vena ophthalmica inferior. (05 Mar 2000) |
| ophthalmic | <anatomy> Pertaining to the eye. (18 Nov 1997) |
| ophthalmic acid | A tripeptide occurring in lens, similar to glutathione but differing in the replacement of cysteine by alpha-amino-n-butyric acid (i.e., in the replacement of -SH by -CH3); a potent inhibitor of glyoxalase. Compare: norophthalmic acid. (05 Mar 2000) |
| ophthalmic artery | <anatomy, artery> Artery originating from the internal carotid artery and distributing to the eye, orbit and adjacent facial structures. (12 Dec 1998) |
| ophthalmic assistants | Persons academically trained to care for patients with eye diseases or structural defects of the eye, under the supervision of an ophthalmologist. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|